PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic extract and lophirones B and C significantly reduced cell viability, with lophirone C showing the best anticancer activity [PMID:24647375].
Leaf extracts exhibited antimicrobial activity with MIC values ranging from 1.0 to 20 μg/mL [PMID:33981891].
Aqueous stem bark extract produced a significant effect in the hole board test (anxiolytic potential) and was tested for antidepressant and anticonvulsant effects [PMID:25781676].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33622229 (2021) — Lophira alata Suppresses Phorbol Ester-Mediated Increase in Cell Growth via Inhibition of Protein Kinase C-α/Akt in Glioblastoma Cells. · Anti-cancer agents in medicinal chemistry
- 2.PMID: 40075285 (2025) — Unlocking the geography of Azobé timber (Lophira alata): revealing spatial genetic structure beyond species boundaries. · BMC plant biology
- 3.PMID: 16933877 (2006) — Minor biflavonoids from Lophira alata leaves. · Journal of natural products
- 4.PMID: 24647375 (2014) — Cytotoxic, antimutagenic, and antioxidant activities of methanolic extract and chalcone dimers (lophirones B and C) derived from Lophira alata (Van Tiegh. Ex Keay) stem bark. · Journal of evidence-based complementary & alternative medicine
- 5.PMID: 25781676